Latest / AudioScholar Neurosurgery Weekly
D2C7 in recurrent glioma well tolerated in single-arm trial
Editor's Pick: EGFR-targeted antibody-toxin conjugate in recurrent glioma: a phase 1 trial (Nature Medicine, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Neurosurgery. This week we're covering 10 notable papers spanning new strategies and surgical risk mapping in brain tumors, radiation as an alternative or partner to surgery, spine surgery for rare and severe disease, and operating when the target is hard to find. Let's dive in.
This week's papers:
EGFR-targeted…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.